These forest plots summarize available COVID-19 vaccine effectiveness against Delta and Omicron variants by vaccine, disease outcome, and study population.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

This file contains a list of neutralization studies identified from an ongoing systematic review of literature evaluating the impact of SARS-CoV 2 variants of concern on COVID-19 vaccine performance. 

These forest plots summarize available COVID-19 vaccine effectiveness data by vaccine and variant of concern. 

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The COVID-19 Maternal Immunization Tracker (COMIT) provides a global snapshot of public health polic

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the 73 Gavi countries

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2020.